Abstract: Cancer remains one of the leading causes of morbidity and mortality international, affecting thousands and thousands of lives each year. While significant strides were made in cancer prevention, detection, and remedy, disparities in healthcare get entry to and outcomes persist, specifically among marginalized populations. One vicinity of problem is the disparity in most cancers’ biopsy prices amongst BIPOC women as compared to their white counterparts.